Commercial Physical & Biological Research Industry - SEC Form 4 Insider Trading Screener

Services Sector - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2018-04-18
IQVIqvia Holdings Inc.Evanisko Michael JDirS - Sale$100.00-8156,101-12%-$81,500
D
2018-04-16
EXELExelixis, Inc.Wyszomierski Jack LDirS - Sale+OE$20.25-14,95993,844-14%-$302,920
D
2018-04-16
EXELExelixis, Inc.Garber Alan MDirS - Sale+OE$20.25-15,00061,329-20%-$303,750
M
2018-04-16
LUNALuna Innovations IncCarilion Clinic10%S - Sale$3.41-39,1722,046,313-2%-$133,522
DM
2018-04-12
LUNALuna Innovations IncCarilion Clinic10%S - Sale+OE$3.39-78,0452,085,485-4%-$264,262
D
2018-04-11
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$20.78-90,000318,604-22%-$1,870,200
2018-04-12
EXASExact Sciences CorpZanotti Katherine SDirS - Sale$45.00-7,232105,814-6%-$325,440
M
2018-04-10
LUNALuna Innovations IncCarilion Clinic10%S - Sale$3.43-44,0122,120,318-2%-$151,014
2018-04-10
EXASExact Sciences CorpDoyle James EdwardDirS - Sale$40.97-3,09835,181-8%-$126,925
2018-04-10
EXASExact Sciences CorpCarey Thomas D.DirS - Sale$39.73-8,44852,410-14%-$335,630
M
2018-04-03
ELOXEloxx Pharmaceuticals, Inc.Shabtai Gilad10%P - Purchase$9.46+8,3003,276,7700%+$78,545
D
2018-04-02
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$28.75-3,00032,600-8%-$86,250
D
2018-04-02
EXASExact Sciences CorpCoward D ScottSVP, GCS - Sale+OE$40.12-2,12270,690-3%-$85,124
2018-03-29
ELOXEloxx Pharmaceuticals, Inc.Shabtai Gilad10%P - Purchase$9.64+4,5003,268,4700%+$43,380
D
2018-03-29
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$29.50-10032,6000%-$2,950
D
2018-03-28
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$28.87-4,06832,600-11%-$117,441
2018-03-26
ELOXEloxx Pharmaceuticals, Inc.Avnur ZafriraDirP - Purchase$9.49+2,0002,263+760%+$18,980
DM
2018-03-26
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$28.66-4,99132,600-13%-$143,043
DM
2018-03-22
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$30.15-35632,600-1%-$10,732
2018-03-23
ELOXEloxx Pharmaceuticals, Inc.Ward RobertCEOP - Purchase$8.99+10,00010,000New+$89,900
2018-03-23
ELOXEloxx Pharmaceuticals, Inc.Weaver Gregory LCFOP - Purchase$8.56+4,5004,500New+$38,520
M
2018-03-21
ELOXEloxx Pharmaceuticals, Inc.Nussbaum RanDirP - Purchase$7.76+12,6007,615,2490%+$97,830
M
2018-03-21
ELOXEloxx Pharmaceuticals, Inc.Kariv TomerDirP - Purchase$7.76+12,6007,615,2490%+$97,830
M
2018-03-21
ELOXEloxx Pharmaceuticals, Inc.Pontifax Management 4 G.P. (2015) Ltd.10%P - Purchase$7.76+12,600427,063+3%+$97,830
2018-03-21
ELOXEloxx Pharmaceuticals, Inc.Avnur ZafriraDirP - Purchase$7.60+263263New+$1,999
DM
2018-03-20
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$31.13-5,61232,600-15%-$174,717
D
2018-03-16
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$31.74-2,38332,600-7%-$75,642
DM
2018-03-14
IQVIqvia Holdings Inc.Parks RobertSVP, ControllerS - Sale+OE$105.73-8962,066-30%-$94,734
DM
2018-03-09
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale+OE$51.98-14,550206,289-7%-$756,271
D
2018-03-12
EXASExact Sciences CorpCoward D ScottSVP, GCS - Sale+OE$52.19-2,70868,124-4%-$141,341
D
2018-03-12
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale+OE$52.19-11,459973,208-1%-$598,091
D
2018-03-12
EXASExact Sciences CorpArora ManeeshCOOS - Sale+OE$52.19-5,295658,613-1%-$276,367
D
2018-03-09
CRLCharles River Laboratories International IncMilne George M JrDirS - Sale+OE$115.00-7,74030,020-20%-$890,100
2018-03-07
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$2.92+1,3601,018,2100%+$3,971
D
2018-03-05
EXELExelixis, Inc.Feldbaum Carl BDirS - Sale+OE$23.88-11,00034,733-24%-$262,680
D
2018-03-05
EXELExelixis, Inc.Cohen CharlesDirS - Sale+OE$24.23-15,000248,180-6%-$363,450
D
2018-03-06
EXELExelixis, Inc.Marchesi Vincent TDirS - Sale+OE$24.73-15,000125,913-11%-$370,950
D
2018-03-06
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale+OE$110.00-24,008352,178-6%-$2,640,880
D
2018-03-06
CRLCharles River Laboratories International IncGirshick BirgitCorporate EVPS - Sale+OE$109.10-9,89322,977-30%-$1,079,343
2018-03-05
IQVIqvia Holdings Inc.Evanisko Michael JDirS - Sale$100.00-8166,916-11%-$81,600
2018-03-06
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$2.73+1,4501,016,8500%+$3,959
2018-03-05
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$2.63+1,5001,015,4000%+$3,945
2018-03-02
AVXLAnavex Life Sciences Corp.Missling Christopher UDir, Pres, CEOP - Purchase$2.41+1,6501,013,9000%+$3,977
D
2018-03-02
EXELExelixis, Inc.Papadopoulos SteliosDirS - Sale+OE$24.05-15,0001,034,314-1%-$360,750
D
2018-03-02
EXELExelixis, Inc.Willsey LanceDirS - Sale+OE$23.91-30,000468,273-6%-$717,300
D
2018-02-28
EXELExelixis, Inc.Haley Patrick J.SVP, CommercialS - Sale+OE$27.13-45,029147,130-23%-$1,221,637
D
2018-02-28
EXELExelixis, Inc.Poste GeorgeDirS - Sale+OE$26.26-15,00083,398-15%-$393,900
ADM
2018-02-26
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale+OE$43.10-39,884206,289-16%-$1,718,847
D
2018-02-28
PRTXProtalex IncKling Arnold PPres, 10%P - Purchase$1.20+18,557,80541,138,954+82%+$22,269,366
2018-02-28
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale$108.43-10013,103-1%-$10,843
D
2018-02-28
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale+OE$107.90-5,24013,203-28%-$565,414
2018-02-28
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$108.47-2,102352,178-1%-$227,995
2018-02-28
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$108.24-4,398306,042-1%-$476,046
2018-02-28
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$108.03-5,102310,440-2%-$551,176
2018-02-28
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$107.81-5,098315,542-2%-$549,639
D
2018-02-28
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale+OE$107.39-3,372320,640-1%-$362,113
D
2018-02-27
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale+OE$108.10-2,15814,078-13%-$233,283
2018-02-27
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$108.41-4,707354,442-1%-$510,282
2018-02-27
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$108.15-7,067308,647-2%-$764,280
2018-02-27
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$107.91-5,993315,714-2%-$646,703
D
2018-02-27
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale+OE$107.66-3,810321,707-1%-$410,199
D
2018-02-27
EXASExact Sciences CorpArora ManeeshCOOS - Sale+OE$44.10-5,512652,633-1%-$243,068
DM
2018-02-26
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale+OE$42.88-35,025211,148-14%-$1,501,960
2018-02-28
SRNESorrento Therapeutics, Inc.Ng George KSee RemarksP - Purchase$9.95+90,000407,935+28%+$895,500
2018-02-28
SRNESorrento Therapeutics, Inc.Ji HenrySee RemarksP - Purchase$9.95+64,6004,348,501+2%+$642,770
D
2018-02-27
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale+OE$44.10-9,085960,267-1%-$400,630
D
2018-02-26
IQVIqvia Holdings Inc.Erlinger III James HSee RemarksS - Sale+OE$100.00-10,00013,494-43%-$1,000,000
2018-02-26
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$108.81-900354,4420%-$97,929
2018-02-26
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$108.43-4,429307,014-1%-$480,232
2018-02-26
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$107.86-5,269311,443-2%-$568,287
2018-02-26
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$107.31-3,999316,712-1%-$429,135
2018-02-26
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$107.00-5,727320,711-2%-$612,779
D
2018-02-26
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale+OE$106.69-4,800326,438-1%-$512,123
2018-02-26
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale$108.53-31914,078-2%-$34,620
D
2018-02-26
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale+OE$107.35-3,86814,615-21%-$415,224
DM
2018-02-23
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale+OE$40.44-27,428218,936-11%-$1,109,266
D
2018-02-26
EXASExact Sciences CorpElliott Jeffrey ThomasCFOS - Sale+OE$42.34-2,98221,793-12%-$126,252
D
2018-02-26
EXASExact Sciences CorpCoward D ScottSVP, GCS - Sale+OE$42.34-4,42052,699-8%-$187,134
D
2018-02-26
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale+OE$42.34-25,319949,327-3%-$1,071,956
D
2018-02-26
EXASExact Sciences CorpArora ManeeshCOOS - Sale+OE$42.34-12,352645,995-2%-$522,959
2018-02-21
INCYIncyte CorpGryska David WEVP, CFOS - Sale$85.56-1,95210,970-15%-$167,013
2018-02-21
INCYIncyte CorpHuber Reid MEVP, Chief Scientific OfficerS - Sale$85.55-1,95835,183-5%-$167,507
2018-02-21
CRLCharles River Laboratories International IncBarbo William DCorporate EVP, CCOS - Sale$108.08-2,32019,156-11%-$250,741
2018-02-16
BASIBioanalytical Systems IncDowning Philip ASVP, Preclinical Srvcs.P - Purchase$1.46+5,00015,765+46%+$7,300
2018-02-16
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale$109.07-3,63911,671-24%-$396,899
A
2017-08-14
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale$97.86-1,30315,310-8%-$127,508
2018-02-15
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$107.50-46343,1230%-$4,945
D
2018-02-15
NRCIANational Research CorpHays Michael D.CEOS - Sale+OE$19.31-5,261,410139,182-97%-$101,597,827
2018-02-15
NRCIANational Research CorpAmandla Mk Trust10%P - Purchase$19.31+5,494,4407,378,645+292%+$106,097,636
D
2018-02-15
CRLCharles River Laboratories International IncChubb Stephen DDirS - Sale+OE$108.69-2,87233,589-8%-$312,172
D
2018-02-13
PIRSPieris Pharmaceuticals, Inc.Orbimed Advisors LLC10%S - Sale+OE$8.98-7,89749,270-14%-$70,915
D
2018-02-09
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale+OE$45.72-101,488920,241-10%-$4,640,272
E
2017-12-19
HPPIHedgepath Pharmaceuticals, Inc.Cross StefanDirP - Purchase$0.27+600,0000-100%+$162,660
E
2017-12-19
HPPIHedgepath Pharmaceuticals, Inc.Mayne Pharma Ventures Pty Ltd10%P - Purchase$0.27+600,000198,106,1320%+$162,660
DM
2018-02-06
SRNESorrento Therapeutics, Inc.Abg Management Ltd10%S - Sale+OE$6.85-662,9127,088,903-9%-$4,542,234
D
2018-02-05
SRNESorrento Therapeutics, Inc.Abg Management Ltd10%S - Sale+OE$8.00-70,7217,751,815-1%-$566,037
DM
2018-01-29
SRNESorrento Therapeutics, Inc.Abg Management Ltd10%S - Sale+OE$7.64-310,0007,822,536-4%-$2,368,864
D
2018-01-25
NRCIANational Research CorpHays Michael D.CEO, 10%S - Sale+OE$39.03-1,602,3995,400,592-23%-$62,541,633
M
2018-01-23
SRNESorrento Therapeutics, Inc.Asia Pacific Medtech (Bvi) Ltd10%S - Sale$7.56-684,2888,617,513-7%-$5,175,690
D
2018-01-23
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale+OE$50.49-110,439920,241-11%-$5,575,961

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top